FindMyKOL
Clinical trialNCT06012721CompletedPhase 1Interventional

Effect of Food on the Pharmacokinetics of ORIC-114

SponsorORIC PharmaceuticalsEnrollment32Food Effect in Healthy Participants
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A randomized, 2-part, 2-sequence, 2-period, open-label, crossover study evaluating the effect of food on the pharmacokinetics (PK) of ORIC-114 tablet formulation in healthy adult subjects.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Nucleus Network Pty Ltd., 235 Ryrie St

    Geelong, Victoria, Australia

  • Nucleus Network Pty Ltd., Level 5, Burnet Tower, 89 Commercial Rd

    Melbourne, Victoria, Australia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ORIC-114
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Sept 2023
Primary completion
23 Nov 2023
Completion
23 Nov 2023
Last update posted
19 Jan 2024
Registered enrollment
32
Registry id
NCT06012721
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.